Sanofi

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: FR0000120578
EUR
83.32
-0.32 (-0.38%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

1.81 M

Shareholding (Dec 2023)

FII

0.03%

Held by 6 FIIs

DII

99.97%

Held by 0 DIIs

Promoter

0.00%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
1

Poor Management Efficiency with a low ROCE of 11.13%

  • The company has been able to generate a Return on Capital Employed (avg) of 11.13% signifying low profitability per unit of total capital (equity and debt)
2

Company's ability to service its debt is strong with a healthy EBIT to Interest (avg) ratio of 19.70

 
3

Poor long term growth as Net Sales has grown by an annual rate of 1.85% and Operating profit at 7.70% over the last 5 years

 
4

Flat results in Jun 25

5

With ROE of 10.62%, it has a Attractive valuation with a 1.49 Price to Book Value

6

Underperformed the market in the last 1 year

stock-summaryMojo Parameters
Mojo Parameters
Stock DNA
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

EUR 105,746 Million ()

stock-summary
P/E

14.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

4.57%

stock-summary
Debt Equity

0.08

stock-summary
Return on Equity

10.62%

stock-summary
Price to Book

1.51

Revenue and Profits:
Net Sales:
8,810 Million
(Quarterly Results - Mar 2015)
Net Profit:
1,055 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
3.25%
0%
3.25%
6 Months
-4.97%
0%
-4.97%
1 Year
-8.13%
0%
-8.13%
2 Years
-5.18%
0%
-5.18%
3 Years
-5.87%
0%
-5.87%
4 Years
-3.71%
0%
-3.71%
5 Years
6.69%
0%
6.69%

Sanofi for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions
News
Icon
No Recent News for the Company
Announcements stock-summary
Icon
No announcement available
Corporate Actions stock-summary
Icon
No corporate action available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
1.85%
EBIT Growth (5y)
7.70%
EBIT to Interest (avg)
19.70
Debt to EBITDA (avg)
0.68
Net Debt to Equity (avg)
0.11
Sales to Capital Employed (avg)
0.45
Tax Ratio
17.98%
Dividend Payout Ratio
88.23%
Pledged Shares
0
Institutional Holding
0.07%
ROCE (avg)
11.13%
ROE (avg)
12.55%
Valuation key factors
Factor
Value
P/E Ratio
14
Industry P/E
Price to Book Value
1.49
EV to EBIT
11.09
EV to EBITDA
7.92
EV to Capital Employed
1.46
EV to Sales
2.76
PEG Ratio
0.80
Dividend Yield
4.63%
ROCE (Latest)
13.12%
ROE (Latest)
10.62%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
Bearish
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bullish
Bearish
Dow Theory
Mildly Bearish
Mildly Bullish
OBV
Mildly Bearish
Mildly Bullish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Dec 2023stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Foreign Institutions

Domestic Funds

Held in 0 Schemes (0%)

Foreign Institutions

Held by 6 Foreign Institutions (0.03%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "alert": "No Quarterly Results declared by Sanofi"
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 8.63% vs -12.05% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is 8.94% vs -39.91% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "41,081.00",
          "val2": "37,817.00",
          "chgp": "8.63%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "13,136.00",
          "val2": "12,267.00",
          "chgp": "7.08%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "596.00",
          "val2": "522.00",
          "chgp": "14.18%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-1,810.00",
          "val2": "-2,099.00",
          "chgp": "13.77%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "5,554.00",
          "val2": "5,098.00",
          "chgp": "8.94%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "231.40%",
          "val2": "205.90%",
          "chgp": "2.55%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]
Annual Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
41,081.00
37,817.00
8.63%
Operating Profit (PBDIT) excl Other Income
13,136.00
12,267.00
7.08%
Interest
596.00
522.00
14.18%
Exceptional Items
-1,810.00
-2,099.00
13.77%
Consolidate Net Profit
5,554.00
5,098.00
8.94%
Operating Profit Margin (Excl OI)
231.40%
205.90%
2.55%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2024 is 8.63% vs -12.05% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2024 is 8.94% vs -39.91% in Dec 2023

stock-summaryCompany CV
About Sanofi stock-summary
stock-summary
Sanofi
Pharmaceuticals & Biotechnology
Sanofi is a healthcare company, focused on patient needs and engaged in the research, development, manufacture and marketing of therapeutic solutions. Its segments are Pharmaceuticals, Human Vaccines (Vaccines), and Other. The Pharmaceuticals segment comprises the commercial operations of various franchises, including Speciality Care (Rare Diseases, Multiple Sclerosis, and Oncology), Diabetes and Cardiovascular, Established Prescription Products, Consumer Healthcare and Generics, and research and development, production and marketing activities for all of the Company's pharmaceuticals operations. The Vaccines segment is dedicated to vaccines and includes the commercial operations of the Company's vaccines division Sanofi Pasteur and dedicated research and development, production and marketing activities for the Company's vaccines operations. Its Rare Diseases products include Cerezyme, Cerdelga, Myozyme and Lumizyme, Fabrazyme, and Aldurazyme. It partners with Alnylam Pharmaceuticals.
Company Coordinates stock-summary
Company Details
54 rue la Boetie , PARIS None : 75008
stock-summary
Tel: 33 1 5377400033 153 774545
stock-summary
Registrar Details